$55.92
0[0.00%]
Last update: 4:20PM Get Real Time Here
Catalent Stock (NYSE:CTLT), Insider Trading Activity
Catalent: Insider buying and selling updated today.
Shares Outstanding
180.974M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | -387 | $56.20 | -$21.75K | SELL | -1.29% | 29.506K | Mar 15 | View |
| Sep 05, 2023 | Michelle Ryan | DIRECTOR | 1K | $49.98 | $49.98K | BUY | 102.15% | 1.979K | Aug 31 | View |
| Sep 01, 2023 | JOHN GREISCH | EXECUTIVE CHAIR | 21K | $50.24 | $1.06M | BUY | 71.93% | 50.196K | Aug 30 | View |
| Aug 25, 2023 | Alessandro Maselli | PRESIDENT & CEO | 1.903K | $44.54 | -$92.24K | GRANT | 2.21% | 88.004K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | 812 | $44.57 | -$11.99K | GRANT | 2.79% | 29.932K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | 724 | $44.50 | -$17.36K | GRANT | 3.05% | 24.449K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Aristippos Gennadios | GROUP PRES. PHARMA & CONSUMER | 1.194K | $44.49 | -$17.62K | GRANT | 1.25% | 96.552K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Steven Fasman | EVP & CHIEF ADMIN OFFICER | 1.409K | $44.65 | -$36.48K | GRANT | 1.95% | 73.789K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Lorenzo Carletti | SVP GLOBAL OPS PH & CONS HLTH | 241 | $44.71 | -$9.66K | GRANT | 2.83% | 8.746K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Jonathan Arnold | SVP, CCO & DIV. HEAD BIOP DEL. | 1.503K | $44.87 | -$3.90K | GRANT | 2.69% | 57.399K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Ricky Hopson | PRES. CLINICAL DEV SUPPLY DIV | 513 | $44.56 | -$12.30K | GRANT | 2.38% | 22.04K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Thomas Hawkeswood | PRES. PHARMA PROD DELIVERY DIV | 121 | $44.72 | -$6.57K | GRANT | 1.63% | 7.533K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Charles Lickfold | SVP, CIO | 447 | $44.72 | -$8.50K | GRANT | 4.10% | 11.339K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Patricia Hunt | PRES. CONSUMER HEALTH DIV | 183 | $44.77 | -$4.75K | GRANT | 1.65% | 11.289K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Ricardo Pravda | CHIEF TRANSFORMATION OFFICER | 702 | $44.47 | -$16.85K | GRANT | 2.38% | 30.224K | Aug 23 - Aug 24 | View |
| Aug 03, 2023 | Ricardo Pravda | CHIEF TRANSFORMATION OFFICER | 9.514K | $47.56 | -$12.79K | GRANT | 47.55% | 29.522K | Aug 01 | View |
| Aug 03, 2023 | Alessandro Maselli | PRESIDENT & CEO | -1.485K | $47.13 | -$69.99K | SELL | -1.70% | 86.101K | Aug 01 | View |
| Aug 03, 2023 | Charles Lickfold | SVP, CIO | 5.187K | $47.90 | -$6.47K | GRANT | 90.92% | 10.892K | Aug 01 | View |
| Aug 03, 2023 | Patricia Hunt | PRES. CONSUMER HEALTH DIV | 1.791K | $47.95 | -$7.72K | GRANT | 19.23% | 11.106K | Aug 01 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.